Repatha (Evolocumab): Legal and Patent Challenges, FDA History, and Regulatory Field
A clinical review of Repatha's FDA approval history, patent disputes with Sanofi/Regeneron, label updates, post-market safety surveillance, and the regulatory path that shaped PCSK9 inhibitor access.